Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-29

Clinical Trial Update: Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication? [NA]

View source ↗

Summary

A clinical trial update examining whether the Voy Program improves weight loss and other health outcomes in individuals already taking GLP/GIP-1RA medication; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Menwell Limited | Conditions: Obesity, Weight Loss | NA | Status: NOT_YET_RECRUITING